Table 1

Comparison of the HRQL scores and health utilities between patients with and without NAFLD-related cirrhosis

Cirrhotic NAFLDNon-cirrhotic NAFLDp ValueAll NAFLD
N305989
Age, years54.1±10.849.1±10.40.046250.8±10.7
Male gender17 (56.7%)22 (37.3%)0.0839 (43.8%)
Race
 Caucasian20 (83.3%)43 (72.9%)0.3163 (75.9%)
 African-American2 (8.3%)6 (10.2%)0.808 (9.6%)
 Hispanic1 (4.2%)4 (6.8%)0.655 (6.0%)
 Asian1 (4.2%)4 (6.8%)0.655 (6.0%)
HRQL and health utilities
 PF (84.5)*37.5±30.8†72.0±22.0†<0.000160.4±30.0†
 RP (81.2)*21.7±35.8†57.5±40.8†0.000145.4±42.5†
 BP (75.5)*53.1±30.7†66.9±23.8†0.036562.2±26.9†
 GH (72.2)*34.1±23.7†58.5±18.1†<0.000150.3±23.1†
 VT (61.1)*29.8±24.2†46.8±19.8†0.001641.1±22.8†
 SF (83.6)*50.0±32.7†78.4±22.50.000168.8±29.4†
 RE (81.3)*38.9±45.6†73.4±37.00.000661.8±43.1†
 MH (74.8)*67.3±18.4†75.8±17.70.051272.9±18.3
 Physical Component Summary (50)*30.4±11.3†42.5±9.8†<0.000138.5±11.8†
 Mental Component Summary (50)*43.0±11.5†49.6±10.30.006847.3±11.1†
 SF-6D health utility (0.78)*0.551±0.138†0.660±0.107†0.00030.623±0.129†
  • *General population mean.21 ,22

  • †p<0.05 when compared to the general population mean.

  • BP, bodily pain; GH, general health; HRQL, health-related quality of life; MH, mental health; NA, not available for the cohort; PF, physical functioning; RE, role emotional; RP, role physical; SF, social functioning; VT, vitality.